+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Allergan Plc
  • Eli Lilly and Company Ltd
  • Hospira Inc
  • Medac Pharma Inc
  • Perrigo Co Plc
  • MORE
Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Critical Information Included
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company that develops, manufactures, and commercializes self-administered parenteral pharmaceuticals and drug delivery systems and technologies. The company’s portfolio encompasses novel therapeutic products for the treatment of polyarticular juvenile idiopathic arthritis, and adults with severe rheumatoid arthritis, severe recalcitrant psoriasis, migraine and cluster headache, and to reduce the risk of preterm birth in pregnant women. It caters its subcutaneous injection technology platforms to both generic and branded injectables. Antares Pharma’s injectables are available in disposable multi-dose pen injectors and unit dose containers. The company employs its drug delivery systems to advance drug compounds and drug delivery methods. It also advances various product development programs in partnership with various leading pharmaceutical companies including Teva and AMAG. The company has a presence in the US and Switzerland. Antares Pharma is headquartered in Ewing, New Jersey, the US.

Antares Pharma Inc Key Recent Developments

Mar 06, 2019 Antares Pharma to Present at the Cowen and Company 39th Annual Healthcare Conference
Mar 04, 2019 Antares Pharma announces board changes
Feb 28, 2019 Antares Pharma Reports Fourth Quarter and Full Year 2018 Operating and Financial Results
Dec 13, 2018 Antares Pharma names Peter S. Greenleaf to company's Board of Directors

Key Benefits Include

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc
  • Allergan Plc
  • Eli Lilly and Company Ltd
  • Hospira Inc
  • Medac Pharma Inc
  • Perrigo Co Plc
  • MORE
Section 1 - About the Company
  • Antares Pharma Inc - Key Facts
  • Antares Pharma Inc - Key Employees
  • Antares Pharma Inc - Key Employee Biographies
  • Antares Pharma Inc - Major Products and Services
  • Antares Pharma Inc - History
  • Antares Pharma Inc - Company Statement
  • Antares Pharma Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 – Company Analysis
  • Company Overview
  • Antares Pharma Inc - Business Description
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Other
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • Antares Pharma Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Antares Pharma Inc - Strengths
  • Antares Pharma Inc - Weaknesses
  • Antares Pharma Inc - Opportunities
  • Antares Pharma Inc - Threats
  • Antares Pharma Inc - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Antares Pharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
  • Mar 06, 2019: Antares Pharma to Present at the Cowen and Company 39th Annual Healthcare Conference
  • Mar 04, 2019: Antares Pharma announces board changes
  • Feb 28, 2019: Antares Pharma Reports Fourth Quarter and Full Year 2018 Operating and Financial Results
  • Dec 13, 2018: Antares Pharma names Peter S. Greenleaf to company's Board of Directors
  • Dec 13, 2018: Antares Pharma announces the appointment of Peter S. Greenleaf to Company’s Board of Directors
  • Sep 17, 2018: Antares Supports Quad-C Management’s Acquisition of NJRetina
  • Aug 07, 2018: Antares Pharma Reports Second Quarter 2018 Operating and Financial Results
  • Aug 06, 2018: Antares Pharma names Dr. James Tursi executive vice president, head of research & development, chief medical officer
  • May 08, 2018: Antares Pharma Reports First Quarter 2018 Operating and Financial Results
  • Mar 13, 2018: Antares Pharma reports fourth quarter and full year 2017 operating and financial results
Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • Antares Pharma Inc, Key Facts
  • Antares Pharma Inc, Key Employees
  • Antares Pharma Inc, Key Employee Biographies
  • Antares Pharma Inc, Major Products and Services
  • Antares Pharma Inc, History
  • Antares Pharma Inc, Other Locations
  • Antares Pharma Inc, Subsidiaries
  • Antares Pharma Inc, Key Competitors
  • Antares Pharma Inc, Ratios based on current share price
  • Antares Pharma Inc, Annual Ratios
  • Antares Pharma Inc, Annual Ratios (Cont...1)
  • Antares Pharma Inc, Interim Ratios
  • Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • Antares Pharma Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Antares Pharma Inc, Performance Chart (2014 - 2018)
  • Antares Pharma Inc, Ratio Charts
  • Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Allergan Plc
  • Mylan NV
  • Sandoz Inc
  • Hospira Inc
  • Eli Lilly and Company Ltd
  • Accord Healthcare Inc
  • Endo Pharmaceuticals Inc
  • Lipocine Inc
  • Acerus Pharmaceuticals Corp
  • Medac Pharma Inc
  • Perrigo Co Plc
  • AbbVie Inc
  • Clarus Therapeutics Inc
  • Teva Pharmaceutical Industries Ltd
Note: Product cover images may vary from those shown
Adroll
adroll